Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarks & Spencer Regulatory News (MKS)

Share Price Information for Marks & Spencer (MKS)

Share Price is delayed by 15 minutes
Get Live Data
361.10    -1.40 (-0.39%)
Bid:
361.00
Ask:
361.50
Spread: 0.50 (0.139%)
Market Cap: £7.42b
MKS Live PriceLast checked at - London Stock Exchange

Intraday Marks & Spencer Share Chart

Director/PDMR Shareholding

24 Jun 2014 14:29

RNS Number : 4163K
Marks & Spencer Group PLC
24 June 2014
 



Marks and Spencer Group Plc (the 'Company') Notification of Transactions Of Directors/Persons Discharging Managerial Responsibility

 

1. Performance Share PlanIt was confirmed on 24 June 2014 that on 23 June 2014 the following awards under the Marks and Spencer Group Performance Share Plan were made to PDMRs of the Company:

Directors

Allocation of Performance Shares

(See Note Below)

Marc Bolland

557,780

Patrick Bosquet-Chavanne 1

300,343

John Dixon

343,249

Steve Rowe

300,343

Alan Stewart

331,235

Laura Wade-Gery

315,789

 

Note: This award was granted as a nil cost option, where a participant will normally be entitled to exercise their award and receive free shares between the third and tenth anniversary of grant, subject to the extent to which performance conditions have been satisfied and their continuing employment 1. The vesting of the award will depend on the Company's earnings per share (EPS), return on capital (ROCE) and Revenue performance over a fixed three-year performance period starting on the first day of the financial year in which the award was granted. The value of dividends accrued, in the form of dividend equivalents, will be paid at the end of period (third anniversary) based on the number of vested Shares. No consideration was paid for the grant of the award. No price is payable on the exercise of the award. For the purposes of this award, the grant was made at a Share price of £4.37

1 Patrick Bosquet-Chavanne award is structured as conditional shares which vest on the third anniversary of grant.

 

3. Shareholdings of PDMRs

Directors

Total Holding of Ordinary Shares

Total Percentage Holding in the Company

Marc Bolland

498,111

De minimis

Patrick Bosquet-Chavanne

2,000

De minimis

John Dixon

276,399

De minimis

Steve Rowe

261,724

De minimis

Alan Stewart

51,622

De minimis

Laura Wade-Gery

118,324

De minimis

The above holdings are at 24 June 2014, being the date of this announcement, and include holdings for Connected Persons.

The above information has been disclosed under DTR 3.1.4

 

For Queries please contact:

Corporate PR +44 (0)20 8718 1919

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSXZLFLZQFLBBV
Date   Source Headline
20th Sep 20233:33 pmRNSHolding(s) in Company
20th Sep 20239:00 amRNSDirector/PDMR Shareholding
19th Sep 20239:01 amRNSDirector/PDMR Shareholding
1st Sep 20239:00 amRNSTotal Voting Rights
30th Aug 202310:34 amRNSDirector/PDMR Shareholding
16th Aug 20233:00 pmRNSDirector/PDMR Shareholding
15th Aug 20237:00 amRNSTrading Update and Outlook for the Year
1st Aug 20239:00 amRNSTotal Voting Rights
28th Jul 202311:33 amRNSDirector/PDMR Shareholding
7th Jul 20234:18 pmRNSDirector/PDMR Shareholding
4th Jul 20232:13 pmRNSResult of AGM
3rd Jul 20239:00 amRNSTotal Voting Rights
3rd Jul 20239:00 amRNSBlock listing Interim Review
28th Jun 20232:01 pmRNSDirector/PDMR Shareholding
19th Jun 20234:41 pmRNSDirector/PDMR Shareholding
8th Jun 20235:01 pmRNSHolding(s) in Company
7th Jun 20232:56 pmRNSHolding(s) in Company
6th Jun 202310:00 amRNSAnnual Financial Report
1st Jun 202312:19 pmRNSDirector/PDMR Shareholding
1st Jun 20239:00 amRNSTotal Voting Rights
24th May 20237:00 amRNSFinal Results
2nd May 20239:00 amRNSTotal Voting Rights
28th Apr 202310:40 amRNSDirector/PDMR Shareholding
3rd Apr 20239:00 amRNSTotal Voting Rights
28th Mar 20232:04 pmRNSDirector/PDMR Shareholding
20th Mar 20233:53 pmRNSHolding(s) in Company
1st Mar 20239:00 amRNSTotal Voting Rights
28th Feb 202310:23 amRNSDirector/PDMR Shareholding
24th Feb 20239:00 amRNSDirectorate Change
1st Feb 20239:00 amRNSTotal Voting Rights
30th Jan 202310:18 amRNSDirector/PDMR Shareholding
16th Jan 20231:35 pmRNSHolding(s) in Company
16th Jan 202310:30 amRNSChange to Board Committee Membership
13th Jan 20234:16 pmRNSHolding(s) in Company
12th Jan 20237:00 amRNSChristmas 2022/2023 Trading
5th Jan 20234:02 pmRNSHolding(s) in Company
3rd Jan 20239:00 amRNSTotal Voting Rights
3rd Jan 20239:00 amRNSBlock listing Interim Review
29th Dec 202210:40 amRNSDirector/PDMR Shareholding
13th Dec 202210:37 amRNSDirector Declaration
12th Dec 20221:45 pmRNSDirectorate Change
9th Dec 20223:27 pmRNSDirector/PDMR Shareholding
1st Dec 20229:00 amRNSTotal Voting Rights
29th Nov 20221:36 pmRNSDirector/PDMR Shareholding
18th Nov 202210:00 amRNSDirectorate Change
11th Nov 202212:48 pmRNSHolding(s) in Company
10th Nov 20224:37 pmRNSHolding(s) in Company
9th Nov 20227:00 amRNSHalf-year Report
1st Nov 20229:00 amRNSTotal Voting Rights
28th Oct 202211:43 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.